Tessera Therapeutics
Mohit Gupta is a Senior Scientist at Tessera Therapeutics, focusing on pioneering research and process development of lipid nanoparticles (LNPs) aimed at targeted gene delivery to the liver and other areas. Prior experience includes serving as Scientist-II at GreenLight Biosciences, where LNPs were developed for vaccine and gene therapy applications. As a Postdoctoral Scholar at Oregon Health & Science University, Mohit advanced lipid libraries and LNP formulations for organ-selective RNA delivery, and held a similar role at Oregon State University. A research assistant position at Duquesne University involved designing and synthesizing novel sigma-2 receptor modulators in partnership with Cognition Therapeutics, Inc. Educational credentials include a PhD in Organic Synthesis and Drug Design from Duquesne University, an MS in Medicinal Chemistry from the National Institute of Pharmaceutical Education and Research, and a Bachelor's in Pharmacy from Delhi University.
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.